The Effect of Artificial Sweeteners on Blood Glucose Response

NCT ID: NCT01246492

Last Updated: 2012-05-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2010-11-30

Study Completion Date

2011-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine whether the presece of the artificial sweeteners aspartame, saccharin and asceulfame-k affect the blood glucose responses to an orally incested glucose solution.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Sweet taste receptors, similar to those located on the lingual taste buds have been located along in the lining of the gut. Recent studies have demonstrated that activation of these sweetness taste receptors, either by sugars such as glucose, fructose, lactose, or artificial sweeteners such as saccharin and aspartame can influence the way nutrients, including glucose are absorbed from the gut into the bloodstream. Studies in animal models have shown that activation of the sweet taste receptors can increase the expression of the sodium-dependant glucose transporter 1 (SGLT1) and glucose transporter 2 (GLUT2) which transport glucose from the lumen into the bloodstream. Thus providing a potential mechanism by which glucose uptake can be regulated. Although artificial sweeteners stimulate the sweet taste receptors, they have little nutritive value, so that when they are consumed in the absence of any other nutrients there is little effect on blood glucose response. However, the effects of consuming artificial sweeteners in combination with sugars such as glucose is unclear. The purpose of this study is to investigate whether the addition of artificial sweeteners to an orally consumed glucose solution affects the rate at which the glucose appears in the blood.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Taste Receptors Nutrient Sensing Intestinal Absorption Blood Glucose Appetite

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

45g glucose

glucose water

Group Type PLACEBO_COMPARATOR

Artificial Sweeteners

Intervention Type DIETARY_SUPPLEMENT

A 400mL drink sweetened with 45g glucose and artificial sweetener will be consumed orally

45g glucose + 150mg aspartame

glucose water aspartame

Group Type ACTIVE_COMPARATOR

Artificial Sweeteners

Intervention Type DIETARY_SUPPLEMENT

A 400mL drink sweetened with 45g glucose and artificial sweetener will be consumed orally

45g glucose + 20 mg saccharin

glucose water saccharin

Group Type ACTIVE_COMPARATOR

Artificial Sweeteners

Intervention Type DIETARY_SUPPLEMENT

A 400mL drink sweetened with 45g glucose and artificial sweetener will be consumed orally

45g glucose + 85mg asculfame - K

glucose water aseulfame- k

Group Type ACTIVE_COMPARATOR

Artificial Sweeteners

Intervention Type DIETARY_SUPPLEMENT

A 400mL drink sweetened with 45g glucose and artificial sweetener will be consumed orally

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Artificial Sweeteners

A 400mL drink sweetened with 45g glucose and artificial sweetener will be consumed orally

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy subjects
* Aged 18-45 years
* BMI (19-25 kg/m2)
* Weight stable in past 3 months

Exclusion Criteria

* Smoking
* Females who are pregnant of breastfeeding
* Regular intake of emdication, other than females taking oral contraceptives
* Medical illness
* Gastrointestinal disorders
* Food allergies
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Northumbria University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Northumbria University

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nerys M Astbury, PhD

Role: PRINCIPAL_INVESTIGATOR

Northumbria University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Brain, Performance and Nutrition Research Centre- Northumbria University

Newcastle upon Tyne, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

34AK1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Metabolic Effects of Non-Nutritive Sweeteners
NCT01200940 COMPLETED PHASE1/PHASE2